- August 22, 2019
Nothing to speak of: when silence is golden after Woodward v Phoenix Healthcare Distribution
Background The underlying dispute in Woodward and another v Phoenix Healthcare Distribution Ltd concerned the alleged mis-sale of a drug by the respondent whilst still under patent to a company which claimed that, as a result of the respondent’s breach of contract or misrepresentations, it suffered financial loss in excess of £5 million and which … Continue reading Nothing to speak of: when silence is golden after Woodward v Phoenix Healthcare Distribution →